"Emerging Markets"

For some of the worlds biggest money managers, the OPEC+ oil-price feud is little more than a sideshow when it comes to emerging markets.

Emerging-market investors reeling from last month's losses head into the first full week of April bracing for more pain driven by higher U.S. Treasury yields and a stronger dollar.

Record low interest rates, rising commodity prices and improved mobility data have been buoying expectations of a recovery across emerging markets even as investors cast a wary eye toward November's U.S. presidential election.

The pile of distressed debt in emerging markets that ballooned in March is quickly shrinking, suggesting to some investors that fears of a wave of corporate collapses are overblown.

Emerging markets are about to find out just how much rougher April will be for them than developed economies. The signals are in the price swings anticipated by traders.

In recent weeks, economic activity across emerging markets has come to a halt, currencies have weakened and equity markets have fallen as coronavirus has swept across the globe. While this situation is rather unique, it isn’t the first time in my career that a crisis has hit.

The collapse in Opec+ negotiations over the weekend of March 7 and Saudi Arabia’s subsequent, aggressive undercutting of its official selling prices signals a break from four years of cohesion and coordination in oil strategy.

Emerging markets are about to end a turbulent year in which U.S.-China trade tensions dominated headlines and central banks around the world came to rescue the global economy from falling into a recession.

BTS Group Holdings has been selected for the second time by the Dow Jones Sustainability Indices (DJSI) for Emerging Markets in the Transportation category.

Chinese equities remain attractive despite the prolonged Sino-US trade war and the global economic slowdown, according to Citibank analysts.

Thailand and other emerging market economies are becoming more attractive to investors amid expectations of cuts in US benchmark interest rates this year, say private bankers.

MEGA Lifesciences (MEGA) yesterday announced its plan to expand into the potential emerging markets of Southeast Asia, Central and Latin America, sub-Saharan Africa and the post-Soviet countries that offer strong growth potential. The expansion is in line with the company’s target to double its business by 2025.